Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care

Rosenberg SR(2012)An integrated approach to the medical treatment of chronic obstructive pulmonary disease Med Clin North Am 96 811-826

Kalhan R(2010)Is pharmacologic care of chronic obstructive pulmonary disease consistent with the guidelines? Popul Health Manag 13 21-26

Diette GB(2011)Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis Curr Med Res Opin 27 1425-1429

Orr P(2011)Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians Int J Chron Obstruct Pulmon Dis 6 171-179

McCormack MC(2012)Barriers to adherence to COPD guidelines among primary care providers Respir Med 106 374-381

Gandy W(2011)Disease severity and symptoms among patients receiving monotherapy for COPD Prim Care Respir J 20 46-53

Hamar B(2014)COPD management costs according to the frequency of COPD exacerbations in UK primary care Int J Chron Obstruct Pulmon Dis 9 65-73

Fitch K(2015)Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study COPD 12 267-275

Iwasaki K(2006)A Cross-Sectional Comparison of Direct Medical Care Costs among COPD and Asthma Patients Living in the Community in Northern Ireland Treat Respir Med 5 495-501

Pyenson B(2014)Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend Am Health Drug Benefits 7 98-106

Rosenberg SR(2012)An integrated approach to the medical treatment of chronic obstructive pulmonary disease Med Clin North Am 96 811-826

Kalhan R(2010)Is pharmacologic care of chronic obstructive pulmonary disease consistent with the guidelines? Popul Health Manag 13 21-26

Diette GB(2011)Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis Curr Med Res Opin 27 1425-1429

Orr P(2011)Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians Int J Chron Obstruct Pulmon Dis 6 171-179

McCormack MC(2012)Barriers to adherence to COPD guidelines among primary care providers Respir Med 106 374-381

Gandy W(2011)Disease severity and symptoms among patients receiving monotherapy for COPD Prim Care Respir J 20 46-53

Hamar B(2014)COPD management costs according to the frequency of COPD exacerbations in UK primary care Int J Chron Obstruct Pulmon Dis 9 65-73

Fitch K(2015)Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study COPD 12 267-275

Iwasaki K(2006)A Cross-Sectional Comparison of Direct Medical Care Costs among COPD and Asthma Patients Living in the Community in Northern Ireland Treat Respir Med 5 495-501

Pyenson B(2014)Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend Am Health Drug Benefits 7 98-106